The pcPPT-mPGK-attR-sLPmCherry-WPRE vector is a metastatic-niche labelling system. This lentiviral backbone plasmid contains a soluble peptide (SP) and a modified TAT peptide cloned upstream of the mCherry gene, under the…
[…] often referred to as the tumour matrisome (Socovich and Naba, 2018). Not only is this tumour microenvironment (TME) critical for the growth and spread of human cancers but also the non-malignant […]
[…] referred to as the tumor matrisome (Socovich and Naba, 2018). Not only is this tumor microenvironment (TME) critical for the growth and spread of human cancers but also the non-malignant […]
[…] often referred to as the tumor matrisome (Socovich and Naba, 2018). Not only is this tumour microenvironment (TME) critical for the growth and spread of human cancers but also the non-malignant […]
[…] often referred to as the tumour matrisome (Socovich and Naba, 2018). Not only is this tumour microenvironment (TME) critical for the growth and spread of human cancers but also the non-malignant […]
[…] microenvironment or genetic changes, is known to have an important role in the growth of experimental tumours. HIF1A has been observed in varying subsets of tumour cells from various solid tumours.
CXCL16, a newly discovered CXC chemokine, exists both in a transmembrane and a soluble form. The membrane bound chemokine act as a ligand for CXC chemokine receptor (CXCR) 6 which…
Monoclonal antibody directed against FGF-3, key for investigating breast carcinogenesis resulting from MMTV.
Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers.
[…] strictly controlling degradation of ECM. The MMPs and TIMPs have a significant role in facilitating tumour invasion and metastasis._x000D_ _x000D_ Expression of MMP9 has been identified in individual studies as […]
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
